Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Atara Biotherapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 145 | 3 | 134 | −8 |
| Shares | 97.9M | 56.7K | 99.8M | +1.98M (+2.0%) |
| Value | $909.5M | $526.0K | $777.4M | −$131.5M (−14.5%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 744,186 | $5.80M | 0.03% |
| Healthcare of Ontario Pension Plan Trust Fund | 616,900 | $4.81M | 0.02% |
| Bank of Montreal | 153,799 | $1.09M | 0.00% |
| Thrivent Financial for Lutherans | 73,642 | $573.0K | 0.00% |
| Jefferies Group LLC | 70,000 | $545.3K | 0.02% |
| Raymond James & Associates | 65,223 | $508.0K | 0.00% |
| Caption Management, LLC | 52,000 | $405.0K | 0.04% |
| Josh Arnold Investment Consultant, LLC | 30,000 | $234.0K | 0.30% |
| Mirae Asset Global Investments Co., Ltd. | 27,000 | $211.0K | 0.00% |
| Jane Street Group, LLC | 25,146 | $195.0K | 0.00% |
| Balyasny Asset Management LLC | 18,666 | $146.0K | 0.00% |
| B. Metzler seel. Sohn & Co. AG | 16,121 | $126.0K | 0.00% |
| Principal Financial Group Inc | 16,023 | $124.0K | 0.00% |
| Quantbot Technologies LP | 13,642 | $106.0K | 0.01% |
| Caxton Associates LP | 12,445 | $97.0K | 0.01% |
| Cutler Group LP | 900 | $7.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 846 | $7.00K | 0.00% |
| Dark Forest Capital Management LP | 849 | $7.00K | 0.00% |
| Lindbrook Capital, LLC | 251 | $2.00K | 0.00% |
Sold out (27)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Natixis | 187,800 | $1.75M |
| Canada Pension Plan Investment Board | 104,000 | $966.0K |
| Alps Advisors Inc | 95,682 | $889.0K |
| Vident Investment Advisory, LLC | 74,844 | $695.0K |
| PDT Partners, LLC | 37,030 | $344.0K |
| AQR Capital Management LLC | 33,402 | $310.0K |
| Walleye Capital LLC | 31,847 | $296.0K |
| Trexquant Investment LP | 31,540 | $293.0K |
| Jupiter Asset Management Ltd | 30,950 | $288.0K |
| Nomura Holdings Inc | 25,600 | $243.0K |
| Fox Run Management, L.L.C. | 23,953 | $223.0K |
| Qube Research & Technologies Ltd | 23,670 | $220.0K |
| XTX Topco Ltd | 23,282 | $216.0K |
| AlphaCrest Capital Management LLC | 21,300 | $198.0K |
| Engineers Gate Manager LP | 16,400 | $152.0K |
| Gsa Capital Partners LLP | 14,466 | $134.0K |
| Monashee Investment Management LLC | 10,000 | $93.0K |
| Point72 Hong Kong Ltd | 7,234 | $67.0K |
| Group One Trading, L.P. | 4,288 | $40.0K |
| Geneos Wealth Management Inc. | 2,170 | $20.0K |
| Parallel Advisors, LLC | 208 | $2.00K |
| CWM, LLC | 111 | $1.00K |
| Ellevest, Inc. | 134 | $1.00K |
| Northwestern Mutual Wealth Management Co | 10 | $0 |
| Concord Wealth Partners | 50 | $0 |
| TCWP LLC | 42 | $0 |
| Covestor Ltd | 21 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 31,731 | $295.0K |
| Susquehanna Fundamental Investments, LLC | 14,147 | $131.0K |
| Amalgamated Financial Corp. | 10,796 | $100.0K |